Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform
Molecules · 2024
DOI: 10.3390/molecules29112702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Alessandra Altomare und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences (DISFARM), Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Blueberry Plants, Anthocyanins, Antiviral Agents, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Lombardia, Ministero dell’Università e della Ricerca PON “Ricerca e Innovazione” 2014–2020, Azione IV.4—“Dottorati e contratti di ricerca su tematiche dell’innovazione”, Azione IV.6—“Contratti di ricerca su tematiche Green”.
Abstract (Originalsprache)
Background
The viral main protease (Mpro) of SARS-CoV-2 has been recently proposed as a key target to inhibit virus replication in the host. Therefore, molecules that can bind the catalytic site of Mpro could be considered as potential drug candidates in the treatment of SARS-CoV-2 infections. Here we proposed the application of a state-of-the-art analytical platform which combines metabolomics and protein structure analysis to fish-out potential active compounds deriving from a natural matrix, i.e., a blueberry extract.
Methods
The experiments focus on finding MS covalent inhibitors of Mpro that contain in their structure a catechol/pyrogallol moiety capable of binding to the nucleophilic amino acids of the enzyme’s catalytic site.
Results
Among the potential candidates identified, the delphinidin-3-glucoside showed the most promising results. Its antiviral activity has been confirmed in vitro on Vero E6 cells infected with SARS-CoV-2, showing a dose-dependent inhibitory effect almost comparable to the known Mpro inhibitor baicalin. The interaction of delphinidin-3-glucoside with the Mpro pocket observed was also evaluated by computational studies.
Conclusions
The HRMS analytical platform described proved to be effective in identifying compounds that covalently bind Mpro and are active in the inhibition of SARS-CoV-2 replication, such as delphinidin-3-glucoside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences (DISFARM), Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milan, Italy.
- Unitech OMICs, Università degli Studi di Milano, Viale Ortles 22/4, 20139 Milan, Italy.
- Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Carlo Pascal 36, 20133 Milan, Italy.
- Department of Biomedical Sciences for Health, Università degli Studi di Milano, Via Carlo Pascal 36, 20133 Milan, Italy.
- Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Via Luigi Mangiagalli 25, 20133 Milan, Italy.
- Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Via Carlo Pascal 36, 20133 Milan, Italy.
ORCID-Profile: Alessandra Altomare, Giovanna Baron, Giulio Ferrario, Larissa Della Vedova, Sarah D'Alessandro, Silvia Parapini, Serena Vittorio, Giulio Vistoli, Patrizia Riso, Serena Delbue, Giancarlo Aldini
Förderung
- Regione Lombardia
- Ministero dell’Università e della Ricerca PON “Ricerca e Innovazione” 2014–2020, Azione IV.4—“Dottorati e contratti di ricerca su tematiche dell’innovazione”
- Azione IV.6—“Contratti di ricerca su tematiche Green”
- POR FESR 2014–2020_BANDO Call HUB Ricerca e Innovazione, Regione Lombardia
- UNIMI GSA-IDEA project
Zitieren
APA
Altomare, A., Baron, G., Cambiaghi, G., Ferrario, G., Zoanni, B., Della Vedova, L., Fumagalli, G. M., D'Alessandro, S., Parapini, S., Vittorio, S., Vistoli, G., Riso, P., Carini, M., Delbue, S., & Aldini, G. (2024). Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform. Molecules. https://doi.org/10.3390/molecules29112702
Vancouver
Altomare A, Baron G, Cambiaghi G, Ferrario G, Zoanni B, Della Vedova L, et al. Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform. Molecules. 2024. doi:10.3390/molecules29112702
BibTeX
@article{Altomare2024,
author = {Altomare, Alessandra and Baron, Giovanna and Cambiaghi, Giulia and Ferrario, Giulio and Zoanni, Beatrice and Della Vedova, Larissa and Fumagalli, Giulio Maria and D'Alessandro, Sarah and Parapini, Silvia and Vittorio, Serena and Vistoli, Giulio and Riso, Patrizia and Carini, Marina and Delbue, Serena and Aldini, Giancarlo},
title = {Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29112702}
}
EUVIMED